Menu Search
Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Learn moreSubscribe now
Equities

United Laboratories International Holdings Ltd

ULIHF:PKC

United Laboratories International Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.25
  • Today's Change0.00 / 0.00%
  • Shares traded13.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Oct 18 2024 14:31 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

The United Laboratories International Holdings Limited is an investment holding company principally engaged in the sales of intermediate products, bulk medicine and finished products. The Company operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.

  • Revenue in HKD (TTM)15.30bn
  • Net income in HKD3.18bn
  • Incorporated--
  • Employees15.00k
  • Location
    United Laboratories International Holdings Ltd6 FuK Wang StreetYuen Long Industrial EstateYuen Long Hong KongHKG
  • Phone+852 26871033
  • Fax+852 26871031
  • Websitehttp://www.tul.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.